Related Experiment Video
Updated: Feb 7, 2026

Isolated Hepatic Perfusion as a Treatment for Liver Metastases of Uveal Melanoma
Published on: January 25, 2015
The effect of curing hepatitis C with direct-acting antiviral treatment on endothelial function
Joshua S Davis1,2,3, Melissa Young1, Sandra Lennox1
1Division of Medicine, John Hunter Hospital, Newcastle, NSW, Australia.
Insights
Antiviral treatment for chronic hepatitis C (CHC) improved endothelial function markers, suggesting CHC contributes to cardiovascular risk. However, microvascular reactivity did not change significantly, indicating complex effects on vascular health.
Area of Science:
- Cardiovascular Health
- Hepatology
- Vascular Biology
Background:
- Chronic hepatitis C (CHC) is linked to increased cardiovascular risk.
- The association between CHC and endothelial dysfunction remains unclear.
- This study investigates the impact of antiviral therapy on endothelial function in non-cirrhotic CHC patients.
Purpose of the Study:
- To assess the effect of antiviral treatment on endothelial function in adults with non-cirrhotic chronic hepatitis C.
- To determine if viral clearance improves vascular health markers.
Main Methods:
- A self-controlled, before-and-after study design was employed.
- 16 non-cirrhotic CHC patients received 12 weeks of paritaprevir/ritonavir, ombitasvir, and dasabuvir (PrOD), with ribavirin for genotype-1a.
- Endothelial function was measured using reactive hyperaemia peripheral arterial tonometry (RHPAT) and serum angiopoietin-2 (Ang-2) and E-selectin levels before, during, and after treatment.
Main Results:
- All 16 patients achieved sustained virological response.
- No significant change was observed in RHPAT index during treatment.
- Significant improvements were noted in serum Ang-2 and E-selectin levels post-treatment (P<0.001 for both).
Conclusions:
- Eliminating hepatitis C virus (HCV) viraemia significantly improves endothelial function markers (serum Ang-2, E-selectin).
- Bedside microvascular reactivity (RHPAT) did not show significant changes.
- Chronic HCV infection may be associated with endothelial cell dysfunction, contributing to long-term cardiovascular risk.
Background:
Epidemiological data suggest that chronic HCV infection (CHC) is associated with increased cardiovascular risk, but it is unknown if it is associated with endothelial dysfunction. We aimed to assess the effect of antiviral treatment on endothelial function in non-cirrhotic adults with CHC.
Methods:
Self-controlled before and after study. All patients had genotype-1 CHC and were treated with 12 weeks of paritaprevir/ritonavir, ombitasvir and dasabuvir (PrOD), with ribavirin added for those with genotype-1a infection. Endothelial function was assessed at three time points before antiviral treatment, at treatment weeks 1, 4, 8 and 12, and 12 weeks after the end of treatment. The main assessment tools were reactive hyperaemia peripheral arterial tonometry (RHPAT) and serum concentrations of angiopoietin-2 (Ang-2) and E-selectin.
Results:
A total of 16 patients were enrolled. Mean (sd) age was 51.4 (6.9) years and 11 participants (69%) were male. All 16 patients achieved a sustained virological response. The mean (sd) baseline RHPAT index was 2.05 (0.48), and there was no significant change during treatment (mean within-patient change from baseline to end of treatment =-0.23 [0.45]; P= not significant). There was a significant improvement in both mean Ang-2 (baseline 2.44 [0.79] ng/ml, within-patient change -0.60 [0.44]; P<0.001) and E-selectin (baseline 48.7 [21.5] ng/ml, within-patient change -14.4 [13.0]; P<0.001).
Conclusions:
Removing HCV viraemia is associated with a significant improvement in endothelial function as measured by serum markers, but not in bedside microvascular reactivity. Chronic HCV viraemia may be associated with endothelial cell dysfunction and therefore long-term cardiovascular risk.
Related Concept Videos
Direct-Acting Cholinergic Agonists: Pharmacokinetics
Direct-Acting Cholinergic Agonists: Therapeutic Uses
Adrenergic Agonists: Direct-Acting Agents
These agents can be classified...
Direct-Acting Cholinergic Agonists: Pharmacological Actions
Curing of Concrete
Curing Methods

